China Pharma Holdings Inc (CPHI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
China Pharma Holdings Inc (China Pharma) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded pharmaceutical products. The company provides western and traditional Chinese medicines in the areas of central nervous system (CNS), cardiovascular, cerebrovascular, wound recovery, digestive disease, and infectious diseases. China Pharma offers products in the various dosage forms including lyophilized injectables, capsules, tablets, granules, injectables, and oral fluids. The company markets its products in various provinces through a network of sales offices across China. The company operates through its wholly owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. and Onny Investment Limited. China Pharma is headquartered in Haikou, Hainan, China.
China Pharma Holdings Inc Key Recent Developments
May 17,2017: China Pharma Holdings, Wholly-owned Subsidiary Participated in PharmChina/ API China Conferences
May 12,2017: China Pharma Holdings Reports First Quarter 2017 Financial Results
Mar 31,2017: China Pharma Holdings Reports Full Year 2016 Financial Results
Aug 12,2016: China Pharma Holdings Reports Second Quarter Financial Results
May 17,2016: China Pharma Holdings Reports First Quarter Financial Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1-About the Company 5
China Pharma Holdings Inc-Key Facts 5
China Pharma Holdings Inc-Key Employees 6
China Pharma Holdings Inc-Key Employee Biographies 7
China Pharma Holdings Inc-Major Products and Services 8
China Pharma Holdings Inc-History 10
China Pharma Holdings Inc-Company Statement 11
China Pharma Holdings Inc-Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2-Company Analysis 13
China Pharma Holdings Inc-Business Description 13
China Pharma Holdings Inc-Corporate Strategy 14
China Pharma Holdings Inc-SWOT Analysis 15
SWOT Analysis-Overview 15
China Pharma Holdings Inc-Strengths 15
China Pharma Holdings Inc-Weaknesses 16
China Pharma Holdings Inc-Opportunities 17
China Pharma Holdings Inc-Threats 18
China Pharma Holdings Inc-Key Competitors 19
Section 3-Company Financial Ratios 20
Financial Ratios-Capital Market Ratios 20
Financial Ratios-Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios-Interim Ratios 25
Financial Ratios-Ratio Charts 26
Section 4-Company's Recent Developments 27
May 17, 2017: China Pharma Holdings, Wholly-owned Subsidiary Participated in PharmChina/ API China Conferences 27
May 12, 2017: China Pharma Holdings Reports First Quarter 2017 Financial Results 28
Mar 31, 2017: China Pharma Holdings Reports Full Year 2016 Financial Results 30
Aug 12, 2016: China Pharma Holdings Reports Second Quarter Financial Results 32
May 17, 2016: China Pharma Holdings Reports First Quarter Financial Results 34
Mar 31, 2016: China Pharma Holdings Reports Full Year 2015 Financial Results 36
Section 5-Appendix 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
List of Figures
China Pharma Holdings Inc, Performance Chart (2012-2016) 24
China Pharma Holdings Inc, Ratio Charts 26
List of Tables
China Pharma Holdings Inc, Key Facts 5
China Pharma Holdings Inc, Key Employees 6
China Pharma Holdings Inc, Key Employee Biographies 7
China Pharma Holdings Inc, Major Products and Services 8
China Pharma Holdings Inc, History 10
China Pharma Holdings Inc, Subsidiaries 12
China Pharma Holdings Inc, Key Competitors 19
China Pharma Holdings Inc, Ratios based on current share price 20
China Pharma Holdings Inc, Annual Ratios 21
China Pharma Holdings Inc, Annual Ratios (Cont...1) 22
China Pharma Holdings Inc, Annual Ratios (Cont...2) 23
China Pharma Holdings Inc, Interim Ratios 25
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41
Single User License:
Corporate User License:
China Pharma Holdings Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
select a license
NEWSLETTER BY CATEGORY
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"